Modeling of Artificial 3D Human Placenta

The placenta is the main organ that allows the fertilized oocyte to develop and mature. It allows the fetus to grow in the prenatal period by transferring oxygen and nutrients between the mother and the fetus. It acts as a basic endocrine organ which creates the physiological changes related to pregnancy and birth in the mother. Removal of wastes and carbon dioxide from the fetus is also achieved by the placenta. It prevents the rejection of the fetus and protects the fetus from harmful effects. Research on the human placenta focuses on understanding the placental structure and function to illuminate the complex structure of this important organ with technological advances. The structure and function of the placental barrier have been investigated with in vitro studies in 2D/3D, and various results have been published comparatively. In this review, we introduce the nature of the placenta with its 3D composition which has been called niche. Different cell types and placental structures are presented. We describe the systems and approaches used in the creation of current 3D placenta, placental transfer models as 3D placental barriers, and micro-engineered 3D placenta on-a-chip to explore complicated placental responses to nanoparticle exposure.

[1]  P. Ertl,et al.  A lab-on-a-chip system with an embedded porous membrane-based impedance biosensor array for nanoparticle risk assessment on placental Bewo trophoblast cells , 2020 .

[2]  A. Veiga-Lopez,et al.  Placenta Disrupted: Endocrine Disrupting Chemicals and Pregnancy , 2020, Trends in Endocrinology & Metabolism.

[3]  H. Bouwmeester,et al.  Combination of the BeWo b30 placental transport model and the embryonic stem cell test to assess the potential developmental toxicity of silver nanoparticles , 2020, Particle and Fibre Toxicology.

[4]  C. Juan,et al.  The Mechanism of the Zika Virus Crossing the Placental Barrier and the Blood-Brain Barrier , 2020, Frontiers in Microbiology.

[5]  R. Fry,et al.  Developing novel in vitro methods for the risk assessment of developmental and placental toxicants in the environment. , 2019, Toxicology and applied pharmacology.

[6]  C. Marsit,et al.  Microorganisms in the Placenta: Links to Early-Life Inflammation and Neurodevelopment in Children , 2019, Clinical Microbiology Reviews.

[7]  Nicole N. Hashemi,et al.  Placenta‐on‐a‐Chip: In Vitro Study of Caffeine Transport across Placental Barrier Using Liquid Chromatography Mass Spectrometry , 2019, Global challenges.

[8]  M. Matsusaki,et al.  In vitro placenta barrier model using primary human trophoblasts, underlying connective tissue and vascular endothelium. , 2019, Biomaterials.

[9]  Min Zhang,et al.  A 3D human placenta-on-a-chip model to probe nanoparticle exposure at the placental barrier. , 2019, Toxicology in vitro : an international journal published in association with BIBRA.

[10]  J. Fisher,et al.  Trophoblast–endothelium signaling involves angiogenesis and apoptosis in a dynamic bioprinted placenta model , 2018, Biotechnology and bioengineering.

[11]  R. Kumar,et al.  Fetal cord blood and tissue immune responses to chronic placental inflammation and chorioamnionitis , 2018, Allergy, Asthma & Clinical Immunology.

[12]  P. Wick,et al.  Gold nanoparticle distribution in advanced in vitro and ex vivo human placental barrier models , 2018, Journal of Nanobiotechnology.

[13]  C. Fiala,et al.  Self-Renewing Trophoblast Organoids Recapitulate the Developmental Program of the Early Human Placenta , 2018, Stem cell reports.

[14]  J. Qin,et al.  Placental Barrier-on-a-Chip: Modeling Placental Inflammatory Responses to Bacterial Infection. , 2018, ACS biomaterials science & engineering.

[15]  K. Loeschner,et al.  Translocation of silver nanoparticles in the ex vivo human placenta perfusion model characterized by single particle ICP-MS. , 2018, Nanoscale.

[16]  R. Romero,et al.  Extracellular vesicles generated by placental tissues ex vivo: A transport system for immune mediators and growth factors , 2018, American journal of reproductive immunology.

[17]  T. Ewart,et al.  Extracellular matrix surface regulates self-assembly of three-dimensional placental trophoblast spheroids , 2018, PloS one.

[18]  Sarah F. McComish,et al.  Nanoparticle-induced neuronal toxicity across placental barriers is mediated by autophagy and dependent on astrocytes , 2018, Nature Nanotechnology.

[19]  P. Wick,et al.  An advanced human in vitro co-culture model for translocation studies across the placental barrier , 2018, Scientific Reports.

[20]  H. Redl,et al.  Immunological compatibility status of placenta-derived stem cells is mediated by scaffold 3D structure , 2018, Artificial cells, nanomedicine, and biotechnology.

[21]  F. Wiekhorst,et al.  Magnetic Nanoparticles Interact and Pass an In Vitro Co-Culture Blood-Placenta Barrier Model † , 2018, Nanomaterials.

[22]  B. Çelebi-Saltik Pericytes in Tissue Engineering. , 2018, Advances in experimental medicine and biology.

[23]  D. Huh,et al.  Placental Drug Transport‐on‐a‐Chip: A Microengineered In Vitro Model of Transporter‐Mediated Drug Efflux in the Human Placental Barrier , 2018, Advanced healthcare materials.

[24]  Lindsay A. Parnell,et al.  Maternal microbiomes in preterm birth: Recent progress and analytical pipelines. , 2017, Seminars in perinatology.

[25]  R. Kamm,et al.  A microfluidics assay to study invasion of human placental trophoblast cells , 2017, Journal of The Royal Society Interface.

[26]  S. Stock,et al.  Preterm birth: Inflammation, fetal injury and treatment strategies. , 2017, Journal of reproductive immunology.

[27]  Peter Wick,et al.  A 3D co-culture microtissue model of the human placenta for nanotoxicity assessment. , 2016, Nanoscale.

[28]  Samuel Parry,et al.  A microphysiological model of the human placental barrier. , 2016, Lab on a chip.

[29]  M. Shahjahani,et al.  Role of stem cell factor in the placental niche , 2016, Cell and Tissue Research.

[30]  D. Huh,et al.  Placenta-on-a-chip: a novel platform to study the biology of the human placenta , 2016, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[31]  Vivek Gupta,et al.  Microfluidics‐based 3D cell culture models: Utility in novel drug discovery and delivery research , 2016, Bioengineering & translational medicine.

[32]  R. Romero,et al.  Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance. , 2015, American journal of obstetrics and gynecology.

[33]  Bram G. Sengers,et al.  Computational modelling of fatty acid transport in the human placenta , 2015, 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[34]  H. Krug,et al.  Bidirectional Transfer Study of Polystyrene Nanoparticles across the Placental Barrier in an ex Vivo Human Placental Perfusion Model , 2015, Environmental health perspectives.

[35]  N. Denora,et al.  Oxcarbazepine-loaded polymeric nanoparticles: development and permeability studies across in vitro models of the blood–brain barrier and human placental trophoblast , 2015, International journal of nanomedicine.

[36]  J. Guibourdenche,et al.  Angiogenin Expression during Early Human Placental Development; Association with Blood Vessel Formation , 2014, BioMed research international.

[37]  Günter P. Wagner,et al.  A case for positive pleiotropy between endometrial and malignancy phenotypes , 2014 .

[38]  Donald E Ingber,et al.  Microfabrication of human organs-on-chips , 2013, Nature Protocols.

[39]  Hazem Ali,et al.  Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model. , 2013, International journal of pharmaceutics.

[40]  B. van Ravenzwaay,et al.  Assessment of an in vitro transport model using BeWo b30 cells to predict placental transfer of compounds , 2013, Archives of Toxicology.

[41]  C. Ronsmans,et al.  Maternal Morbidity and Disability and Their Consequences: Neglected Agenda in Maternal Health , 2012, Journal of health, population, and nutrition.

[42]  P. Wick,et al.  Knocking at the door of the unborn child: engineered nanoparticles at the human placental barrier. , 2012, Swiss medical weekly.

[43]  G. Koren,et al.  The Human Placental Perfusion Model: A Systematic Review and Development of a Model to Predict In Vivo Transfer of Therapeutic Drugs , 2011, Clinical pharmacology and therapeutics.

[44]  Yuping Wang Vascular Biology of the Placenta , 2010 .

[45]  Jesper B Nielsen,et al.  Placental transport and in vitro effects of Bisphenol A. , 2010, Reproductive toxicology.

[46]  Peter Wick,et al.  Barrier Capacity of Human Placenta for Nanosized Materials , 2009, Environmental health perspectives.

[47]  Margaret Saunders,et al.  Transplacental transport of nanomaterials. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[48]  S. Badylak,et al.  A perivascular origin for mesenchymal stem cells in multiple human organs. , 2008, Cell stem cell.

[49]  A. Moffett,et al.  Immunology of placentation in eutherian mammals , 2006, Nature Reviews Immunology.

[50]  Asphalt Pavement Mixes,et al.  DEVELOPMENT OF A , 2011 .

[51]  J. Keelan,et al.  Drug Transfer and Metabolism by the Human Placenta , 2004, Clinical pharmacokinetics.

[52]  R. Redline Placental inflammation. , 2004, Seminars in neonatology : SN.

[53]  J. Frendo,et al.  Angiogenin Distribution in Human Term Placenta, and Expression by Cultured Trophoblastic Cells , 2004, Angiogenesis.

[54]  T. Ma,et al.  Development of an in vitro human placenta model by the cultivation of human trophoblasts in a fiber-based bioreactor system. , 1999, Tissue engineering.

[55]  J. Unadkat,et al.  In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus. , 1999, American journal of obstetrics and gynecology.

[56]  M. Murray,et al.  Embryo Implantation and Tumor Metastasis: Common Pathways of Invasion and Angiogenesis , 1999, Seminars in reproductive endocrinology.

[57]  K. Audus,et al.  Permeability properties of monolayers of the human trophoblast cell line BeWo. , 1997, The American journal of physiology.

[58]  A. Weindling Fetal and Neonatal Pathology , 1994, Archives of disease in childhood.

[59]  H. Fox,et al.  Ultrastructure of the normal human placenta. , 1991, Electron microscopy reviews.

[60]  H. Koffler,et al.  Fetal and Neonatal Physiology , 1981, Pediatric Research.